Subaru of America, Inc. today announced the completion of a Pet Travel Seat Pilot Study as part of its continued partnership with Center for Pet Safety (CPS), a registered 501(c)(3) non-profit research and consumer advocacy organization. Subaru and CPS have tested pet products most commonly used by pet parents when traveling. Phase one tested pet harnesses, phase two tested pet crates and carriers, and now, phase three has tested pet travel seats.
A pet travel seat is typically used in a vehicle to hold or elevate the pet, but does not offer full containment. The Pet Travel Seat Pilot Study found that while a pet travel seat may offer distraction prevention, it will likely not offer crash protection in the event of an accident, which could lead to injury of the pet and the human vehicle passengers. The quality of commonly available pet travel seats did not provide effective protection in a crash scenario.
Based on the scientific test evidence collected over the past four years, in part through its partnership with Subaru, CPS can now identify the safest travel options for most pets. For small dogs and cats, Center for Pet Safety recommends one of the 2015 Top Performing Carriers; for medium and large dogs either the 2015 Top Performing Crate - Gunner Kennels G1 Intermediate with 8' Tie Down Straps, or a Center for Pet Safety Certified Harness. To view top performing products and CPS Certified products, visit www.CenterforPetSafety.org.
To view the multimedia release go to:
http://www.multivu.com/players/English/7074158-subaru-cps-pet-travel-seat-study/
Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) for the treatment of coronary artery disease.
With this FDA approval, Boston Scientific will commence commercialization of the first and only BP-DES in the U.S. Notably, both the drug coating and the polymer – which modulates drug release – are fully absorbed shortly after drug elution is complete at three months.
The SYNERGY Stent provides synchronized drug and polymer absorption. It is designed to enable more rapid and complete arterial healing, and to thereby reduce the risk of complications associated with long-term polymer exposure compared to currently-used drug-eluting stents (DES) with permanent polymers.
To view the multimedia release go to:
http://www.multivu.com/players/English/7223456-boston-scientific-fda-approval-synergy/
The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderson Cancer Center. As LLS leads the charge to find cures for cancer patients, this new funding, along with ongoing investment in LLS’s aggressive research agenda, brings LLS’s total commitment to blood cancer research to more than $1 billion. The investment has led to the development of nearly every therapy currently used to treat the blood cancers.
Along with these new research grants, LLS remains committed to collaborating with biotechnology companies through its innovative Therapy Acceleration Program® (TAP), a model pioneered by LLS in the cancer arena in recognition that traditional research approaches weren’t yielding treatments and cures fast enough for patients. LLS commits approximately $13 million a year to its TAP initiatives. As part of the 24 current such collaborations, LLS recently initiated new investments with Kite Pharma and OncoPep.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554852-lls-cancer-research-funding/
What does it look like to really live a full life – one that enriches and satisfies, that provides happiness and enables achievement? Abbott is talking to one million people worldwide to find out. And the answers aren’t as simple as you would think.
Does living fully look the same to an accountant in Shanghai as it does to an architect in New Delhi or a street artist in São Paulo? What about a factory worker in Detroit or a new mother in Berlin? In today’s hyperconnected world that is pulling us together in so many ways, how do our cultural differences, life experiences and personalities influence what it means to live a full life?
Early in this quest we’re seeing preliminary trends, like the role health plays in a full life in Shanghai and the importance of family in New York. We’ll have to see if this is confirmed as we go global with our research. The one thing that is becoming apparent is just how personal it gets when we talk to people about life.
This global quest is at the heart of what our company does—finding answers that have helped people live healthier, better lives for more than 125 years.
To view the multimedia release go to:
http://www.multivu.com/players/English/7611051-abbott-live-fully/
As more than 2 million freshman head off to college, they enter one of the most dangerous times for harmful and underage student drinking—the first six weeks of their first year. And while there are numerous options available to address student drinking -- they are not all equally effective.
WHAT: The NIH’s National Institute on Alcohol Abuse and Alcoholism will hold a press briefing to announce the CollegeAIM (Alcohol Intervention Matrix) guide and website – the centerpiece of which is a new comprehensive and easy-to-use tool that will help inform decisions about alcohol interventions and guide college staff to science-based strategies.
Developed with input from leading alcohol researchers and college staff, CollegeAIM is distinctive because of the number and expertise of its contributors, the breadth of research covered by its analysis, and its user-friendly format.
To view the multimedia release go to:
http://www.multivu.com/players/English/7587851-niaaa-collegeaim-alcohol-intervention/
Nearly three in four American voters (74 percent) favor increasing federal funding for cancer research, according to the results of a new national survey conducted on behalf of the American Association for Cancer Research (AACR). The survey results were released today in conjunction with the AACR’s fifth annual Cancer Progress Report. The report highlights how federally funded research can power progress against cancer and urges Congress and the administration to implement a strategy for providing annual budget increases of at least 7 percent for the National Institutes of Health (NIH), National Cancer Institute (NCI), and U.S. Food and Drug Administration (FDA) in fiscal year 2016 and thereafter.
The national survey, which was conducted by Hart Research Associates and Public Opinion Strategies, shows that five out of every six voters recognize what the AACR Cancer Progress Report 2015 details: that progress is being made against cancer.
To view the multimedia release go to:
http://www.multivu.com/players/English/7613551-aacr-cancer-research-survey/
Lake Research Partners and Bellwether Research and Consulting recently released a new national poll sponsored by the American Motorcyclist Association (AMA) that finds likely 2016 voters have widespread and serious concerns about ethanol’s unintended consequences—including damage to engines, land conversion and food prices.
“Voters across party lines express grave concerns for the impacts of the corn ethanol mandate from the Renewable Fuel Standard that touch many parts of their lives from the cars they drive to the food they buy,” said Celinda Lake, president of Lake Research Partners. “They strongly support bi-partisan proposals that would reduce the impact of corn ethanol, and particularly support the Environmental Protection Agency reducing the amount of corn ethanol required by law.”
As the EPA recently closed the comment period on its proposed ethanol volumes for 2014, 2015 and 2016, the poll also shows that 67 percent of people favor the agency setting ethanol volumes below what is required by law, with 68 percent of Democrats and 71 percent of Republicans supporting volumes lower than the statute.
To view the multimedia release go to: http://www.multivu.com/players/English/7576751-ama-national-ethanol-voter-poll/
The National Insurance Crime Bureau (NICB) is warning drivers to take their keys and lock their vehicles, or risk becoming a statistic. Some 45,000 drivers last year admitted that they had left their keys in the car when it was stolen.
“This may sound like a broken record,” said NICB President and CEO Joe Wehrle. “But the simple fact is, too many people make it easy for car thieves. We repeatedly warn motorists to lock it up and take the keys, but our research shows that in too many cases, that’s not happening. Today’s vehicles have excellent anti-theft systems, but they don’t work if you don’t use them.”
The new PSA, “If Only Cars Could Talk,” uses animated cars to drive home the point that a thoughtless driver may regret the decision to leave the car unlocked with the keys inside because they are only making a quick stop.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7523154-nicb-psa-warns-of-car-and-cargo-theft/
The St. Baldrick’s Foundation, a volunteer-powered charity dedicated to funding children’s cancer research, is recognizing National Childhood Cancer Awareness Month with a number of activities planned throughout September. As the leading non-governmental funder of childhood cancer research grants, St. Baldrick’s is asking people to get involved by helping to raise awareness and funds for childhood cancer research.
“One in five kids with cancer will die in the first five years of diagnosis, and those that do survive face a lifetime of serious health issues caused by the toxicity of their cure,” said Kathleen Ruddy, CEO of St. Baldrick’s. “The American public wants kids with cancer to be a national health priority, but our leaders are leaving these kids behind with the lack of federal research funding. We are calling upon everyone to speak up about the need for increased childhood cancer research funding as well as to stand up in support of kids with cancer during this important month.”
Today, as part of the official kickoff for Childhood Cancer Awareness Month, St. Baldrick’s will ring the opening bell at the NASDAQ Stock Market. St. Baldrick’s board members will be joined by researchers, as well as children and families directly affected by childhood cancer.
To view the multimedia release go to:
http://www.multivu.com/players/English/7610751-st-baldricks-childhood-cancer-awareness-month/
The Leukemia & Lymphoma Society (LLS), the world’s leading voluntary non-profit dedicated to blood cancers, released 30 “proof points” - one for each day of September, Blood Cancer Awareness Month - to demonstrate its impact on the cancer landscape and progress towards a world without blood cancers.
LLS has invested more than $1 billion in research to advance breakthrough therapies and cures for blood cancer patients. In many cases, those treatments are now helping patients with other cancers and chronic diseases. Due to its focus on blood cancers, survival rates are improving. Since the early 1960s, five-year survival rates for many blood cancer patients have doubled, tripled and even quadrupled.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554851-lls-blood-cancer-awareness-month/
This year, parents of nearly 16,000 children in the U.S. will hear the words: “Your child has cancer.” One in five of those children won’t survive. September is Childhood Cancer Awareness Month, and as a leader in the way the world understands, treats and defeats childhood cancer and other life-threatening diseases, St. Jude Children’s Research Hospital® will focus on raising awareness and funds for this very important issue.
Despite significant progress made by St. Jude Children’s Research Hospital, which has helped push the overall childhood cancer survival rates from 20 to more than 80 percent since the hospital opened in 1962, cancer remains the leading cause of death by disease for children over the age of 1. Each year about 175,000 children are diagnosed with cancer worldwide, and 60 percent of these kids don’t have access to modern treatment. For those who win their battles against childhood cancer, victory often comes at a cost as survivors face a much higher risk of experiencing unique long-term health effects later in life.
To view the multimedia release go to:
http://www.multivu.com/players/English/7390851-st-jude-hospital-childhood-cancer-awareness/
Johnson Controls, a global multi-industrial company, is constantly focusing on improving the future of car seating. Thinking ahead, Johnson Controls will present its seating demonstrator vehicle SD15 to customers and media at the 66th Frankfurt Autoshow. The SD15 features a simulated vehicle environment with a focus on first- and second-row seating while addressing the three automotive megatrends from a seating perspective: autonomous driving, lightweight, and increasing customer demands towards individualization and style for future urban mobility.
“The SD15 is based on extensive proprietary research conducted by Johnson Controls that explored what consumers expect as car seating in 2020 and beyond,” said Beda Bolzenius, president of Johnson Controls Automotive Experience. “The driver side demonstrates superior comfort and the passenger side showcases features that maximize cargo capacity and interior flexibility.”
To view the multimedia release visit:
http://www.multivu.com/players/uk/7592351-johnson-controls-new-SD15-seating-vehicle/
